Postpolypectomy Bleeding in Patients With Antiplatelet Therapy

• Status: Unknown status
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if the use of aspirin prior to colonoscopy increases the risk of post polypectomy bleeding. The primary end point is comparison of bleeding rates after polypectomy of a continuous aspirin group and temporally aspirin-quit group. The secondary end point is analysis of risk factors which affect early or delayed post polypectomy bleeding.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Soonchunhyang University Hospital
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• The patients who take low dose aspirin (75~160mg) for primary prevention of vascular disease and low risk for thromboembolism.

Exclusion Criteria:

• The patients who taking anti-thrombotic agents,

• The patients who taking thienopyridines or other NSAID with aspirin,

• The patients who have low platelet count(<80,000/mm3) and prolongated PT/aPTT in laboratory test,

• The patients who have chronic renal disease (creatinine>3mg/dl over 6 months),

• The patients who have polyps over than 1 cm in size or thick pedicle over 1 cm,

• The patients who have GI malignancies,the patients who are over ASA classification class III.